A Case of Giant Cell Arteritis With a Normal Erythrocyte Sedimentation Rate (ESR) Post ChAdOx1 nCoV-19 Vaccination
Open Access
- 27 May 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (5) , e25388
Abstract
Giant cell arteritis (GCA) has been reported post the coronavirus disease 2019 (COVID-19) vaccination, especially with the mRNA vaccine. A normal erythrocyte sedimentation rate (ESR) is seen in some GCA patients. This report describes a 68-year-old gentleman who presented with a right-sided temporal headache for three weeks, starting three to five days after his second dose of the ChAdOx1 nCoV-19 vaccine, a viral vector vaccine, which was given seven weeks post the first dose. On presentation, he developed blurred vision in the left eye, and it progressed to complete vision loss four days later. He also had episodes of blurred vision in the right eye. The blood test showed a mildly elevated C-reactive protein of 29 mg/L and a normal erythrocyte sedimentation rate (ESR) of 4 mm/hr. Optical coherence tomography showed anterior ischaemic optic neuropathy in the left eye and retinal ischemia in the right eye. Bilateral giant cell arteritis (GCA) was confirmed on temporal artery biopsy. He was treated with methylprednisolone pulse therapy followed by prednisolone. He re-presented with intermittent blurry vision in the right eye three months later. He was treated with methylprednisolone pulse therapy again, followed by prednisolone, aspirin, and tocilizumab. This case describes a patient who developed GCA post ChAdOx1 nCoV-19 vaccination with a normal ESR. Further studies are needed to investigate this relationship as causal or incidental and the likelihood of low-level inflammatory makers in such a situation.Keywords
This publication has 17 references indexed in Scilit:
- Case of Giant Cell Arteritis After SARS-CoV-2 Vaccination: A Particular Phenotype?The Journal of Rheumatology, 2021
- Large-vessel giant cell arteritis after COVID-19 vaccineScandinavian Journal of Rheumatology, 2021
- Vasculitis and bursitis on [18F]FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc?European Journal of Nuclear Medicine and Molecular Imaging, 2021
- COVID-19 Recombinant mRNA Vaccines and Serious Ocular Inflammatory Side Effects: Real or Coincidence?Journal of Ophthalmic and Vision Research, 2021
- Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemicAnnals of the Rheumatic Diseases, 2021
- SARS-CoV-2 infection triggering a giant cell arteritisMedicina Clínica (English Edition), 2021
- Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseasesClinical Immunology, 2020
- Infections and the risk of incident giant cell arteritis: a population-based, case-control studyAnnals of the Rheumatic Diseases, 2017
- Giant cell arteritis with an erythrocyte sedimentation rate lower than 50.2000
- Dysphagia with Multiple Autoimmune DiseaseClinical Rheumatology, 2000